MedTrace Logo

Comparison of Mean Duration of Analgesia Following the Administration of Bupivacaine With and Without Magnesium Sulphate in Ultrasound Guided Erector Spinae Plane Block in Modified Radical Mastectomy Patients

NCT07460115 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-03-10

No results posted yet for this study

Summary

To compare mean duration of postoperative analgesia following the administration of bupivacaine with and without magnesium sulphate in erector spinae plane block in modified radical mastectomy patients.

Conditions

  • Modified Radical Mastectomy

Interventions

DRUG

Group B (bupivacaine)

receive 20 ml of 0.25% bupivacaine on the operated side for the Erector Spinae Plane (ESP) block.

DRUG

Bupivacaine plus magnesium sulfate

20 ml of 0.25% bupivacaine plus 250 mg of magnesium sulfate on each side.

Sponsors & Collaborators

  • Gulab Devi Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-28
Primary Completion
2025-11-28
Completion
2025-11-28

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07460115 on ClinicalTrials.gov